Catalyst Wire Dossier Catalyst Wire Dossier

S-303 treated red blood cells

S303-treated red blood cells · Cerus Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S-303 treated red blood cells, covering 2015-12-16 to 2015-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells [Phase 2]

See pricing